Press Releases

Page Category: 

Q4 2009 Operating Income Grows 117% as Operating Margins Hit 15.4% Excluding Non-recurring Items Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA - February 11, 2010 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today reported financial results for the fourth quarter and year ended December 31, 2009.

REVENUE Revenues in the fourth quarter of 2009 were $69.7 million, a decrease of 1% compared to the fourth quarter of 2008. Full year of 2009 revenues were $227.4 million, down 7% versus full year of 2008. Revenues for the partial year acquisition of CardioDynamics were $4.2 million for the fourth quarter and $7.1 million for the full year of 2009. Excluding partial year revenues from CDIC, Sonosite fourth quarter revenues were $65.5 million, down 7% versus the fourth quarter of 2008. Full year revenues excluding CDIC were $220.3 million, a decrease of 10% compared to 2008. Changes in foreign currency rates increased worldwide revenues by 4% in the fourth quarter and decreased revenues by 2% for the full year.

OPERATING INCOME AND CASH FLOW Fourth Quarter Results

BOTHELL, WA – January 21, 2010 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, said today that it will report the company’s fourth quarter financial results on Thursday, February 11, 2010 at the close of market and will host a conference call at 1:30 p.m. PT/4:30 p.m. ET.

The call will be broadcast live and can be accessed via Sonosite’s website at www.sonosite.com/investorinformation/webcasts . A replay of the audio webcast will be available beginning February 11, 2010 at 5:30 p.m. PT and can be accessed until February 25, 2010 at 9:59 p.m. PT by dialing (719) 457-0820 or toll-free (888) 203-1112. The confirmation code 7406921 is required to access the replay. Additionally, the call will be archived on Sonosite’s website.

About Sonosite Sonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care.

BOTHELL, WA – January 19, 2010 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced the commencement of its previously announced tender offer to repurchase up to $100 million of the Company's common stock for cash through a modified "Dutch Auction" tender offer. As previously announced, under the terms of the tender offer, Sonosite shareholders have the opportunity to tender some or all of their shares at a price within the range of $26.10 to $30.00 per share.

Based on the number of shares tendered and the prices specified by the tendering shareholders, Sonosite will determine the lowest per share price within the range that will enable it to buy $100 million in shares, or such lesser number of shares that are properly tendered. All shares accepted for payment will be paid the same price, regardless of whether a shareholder tendered such shares at a lower price within the range. At the minimum price of $26.10 per share, Sonosite would repurchase a maximum of 3,831,417 shares, which represents approximately 22% of Sonosite's currently outstanding common stock.

BOTHELL, WA – January 11, 2010 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced that its Board of Directors has authorized Sonosite to repurchase up to $150 million of the Company’s common stock or outstanding convertible notes for cash. In connection with the repurchase authorization, the company will purchase up to $100 million of the Company’s common stock through a modified “Dutch Auction” tender offer.

Sonosite intends to commence the tender offer during the week of January 18, 2010. Under the terms of the proposed tender offer, Sonosite shareholders will have the opportunity to tender some or all of their shares at a price within the range of $26.10 to $30.00 per share. Based on the number of shares tendered and the prices specified by the tendering shareholders, Sonosite will determine the lowest per share price within the range that will enable it to buy $100 million in shares, or such lesser number of shares that are properly tendered.

BOTHELL, WA – January 5, 2010 – Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today provided preliminary revenue results for the fourth quarter and year ended December 31, 2009. Overall 2009 revenue was approximately $69 million in the fourth quarter and $227 million for the year. Overall revenue included $4 million for the fourth quarter and $7 million for the year from the recently acquired CardioDynamics International Corporation (CDIC). Excluding CDIC, revenue was down 7% in the fourth quarter and down 10% for the year compared to the prior year.

For the quarter, a decrease in military orders caused a 6% revenue decline. Changes in foreign currency rates increased revenue in the fourth quarter by 4% but decreased revenue by 2% for the year. “Exiting 2009, we were encouraged by an uptick in momentum during the fourth quarter,” said Kevin Goodwin, Sonosite President and CEO. “On a constant currency basis, international revenue was level in the fourth quarter and grew 1% for the year. Our US Direct business was down compared to the prior year but continued to grow sequentially. Strong US bookings at the year end and a positive outlook by our sales force have provided some renewed optimism heading into 2010.” The revenue estimates are preliminary. Sonosite plans to report complete fourth quarter and 2009 financial results on February 11, 2010 after the close of the financial markets.

Conference Call Information

BOTHELL, WA – December 28, 2009 – Sonosite, Inc. (Nasdaq: SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that Kevin M. Goodwin, President and CEO, will present at the 28th Annual J.P. Morgan Healthcare Conference being held at the Westin St. Francis Hotel in San Francisco, January 11-14, 2010. Mr. Goodwin’s presentation will be webcast live on January 12, 2010 beginning at 10:30 a.m. Pacific Time. An audio replay will be available for 30 days following and can be accessed via Sonosite’s website at www.sonosite.com/investorinformation/webcasts .

About Sonosite Sonosite, Inc. ( www.sonosite.com ) is the innovator and world leader in hand-carried ultrasound. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. Sonosite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care.

Industry leaders, Decision Makers and Customers Gathered in Europe to Experience the Latest Technology for Patient Safety

BOTHELL, WA - December 7, 2009 – Sonosite Inc., the world leader and specialist in hand-carried ultrasound for the point-of-care, announced today that the company has completed the launch of the 6 pound NanoMaxx™ ultrasound tool in Europe. The latest system to join Sonosite’s suite of specialized products for point-of-care visualization, the NanoMaxx system made its debut during fall exhibitions, road shows and key events hosted in France, Germany, Italy, Spain, UK and a number of other countries. Sonosite hosted various events to introduce the NanoMaxx system. At these gatherings, physicians from multiple medical specialties participated in a day of clinical education and hands on scanning led by key opinion leaders in the industry.

“This was a great opportunity for physicians to learn more about the NanoMaxx system and to be educated on the latest ultrasound practices, especially with risk management and patient safety practices becoming more stringent in the hospital setting,” said Mike Fernandez, Sonosite, General Manager, Europe and Latin America. “With the ability to expedite workflow, guide interventional procedures and provide visualization and diagnostics at any point-of-care location, the NanoMaxx system is truly a powerful tool that will raise the standard of healthcare practices around the globe.”

Thousands of Physicians Worldwide are Benefitting from SonoAccess BOTHELL, WA - November 9, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for point-of-care medicine, today announced the expansion of the SonoAccess™ iPhone® application to include musculoskeletal specialties. SonoAccess is the first iPhone application to provide physicians with a comprehensive multimedia database of ultrasound resource materials.

Dedicated to providing innovative educational tools to musculoskeletal physicians, the SonoAccess app is customized for rheumatologists, orthopedic surgeons, physiatrists and sports medicine physicians. Partnering with leading physicians and educators within the ultrasound community, Sonosite has created a comprehensive library of scanning technique videos with case studies and an expansive image gallery to meet the needs of musculoskeletal physicians.

Conference Call Webcast Live Today at 1:30 pm Pacific/4:30 pm Eastern

BOTHELL, WA - October 27, 2009 - Sonosite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today reported financial results for the third quarter and nine months ended September 30, 2009.

REVENUE Revenue in the third quarter of 2009 was $53.6 million, a decrease of 13% compared to the third quarter of 2008. For the nine months of 2009, revenue was $157.7 million, a decrease of 9% compared to the nine months of 2008. Overall revenue included $3.0 million for the quarter and nine months just ended from the recently acquired CardioDynamics International Corporation (CDIC). Excluding CDIC, revenue in the third quarter was $50.6 million, a decrease of 18% compared to the third quarter of 2008, and $154.7 million for the nine months just ended. Foreign exchange had zero effect on third quarter revenue, but had a negative impact of $6.7 million or 4% for the nine months just ended.

OPERATING INCOME AND CASH FLOW Overall, “reported” third quarter operating income was $2.3 million, including charges from CDIC of $3.1 million related to operating results as well as acquisition and integration. Operating income in the third quarter excluding CDIC was $5.4 million, a 10.7% operating margin versus a $3.0 million or 5.6% operating margin in the second quarter 2009.

Cash Flow